10 results on '"Ezer, Shlomit"'
Search Results
2. Spironolactone inhibits the growth of cancer stem cells by impairing DNA damage response
- Author
-
Gold, Ayala, Eini, Lital, Nissim-Rafinia, Malka, Viner, Ruth, Ezer, Shlomit, Erez, Keren, Aqaqe, Nasma, Hanania, Rotem, Milyavsky, Michael, Meshorer, Eran, and Goldberg, Michal
- Published
- 2019
- Full Text
- View/download PDF
3. Intellectual disability syndrome associated with a homozygous founder variant inSGSM3in Ashkenazi Jews
- Author
-
Birnbaum, Rivka, primary, Ezer, Shlomit, additional, Lotan, Nava Shaul, additional, Eilat, Avital, additional, Sternlicht, Keren, additional, Benyamini, Lilach, additional, Reish, Orit, additional, Falik-Zaccai, Tzipora, additional, Ben-Gad, Gali, additional, Rod, Raya, additional, Segel, Reeval, additional, Kim, Katherine, additional, Burton, Barabra, additional, Keegan, Catherine E, additional, Wagner, Mallory, additional, Henderson, Lindsay B, additional, Mor, Nofar, additional, Barel, Ortal, additional, Hirsch, Yoel, additional, Meiner, Vardiella, additional, Elpeleg, Orly, additional, Harel, Tamar, additional, and Mor-Shakad, Hagar, additional
- Published
- 2023
- Full Text
- View/download PDF
4. Intellectual disability syndrome associated with a homozygous founder variant in SGSM3 in Ashkenazi Jews.
- Author
-
Birnbaum, Rivka, Ezer, Shlomit, Lotan, Nava Shaul, Eilat, Avital, Sternlicht, Keren, Benyamini, Lilach, Reish, Orit, Falik-Zaccai, Tzipora, Ben-Gad, Gali, Rod, Raya, Segel, Reeval, Kim, Katherine, Burton, Barabra, Keegan, Catherine E., Wagner, Mallory, Henderson, Lindsay B., Mor, Nofar, Barel, Ortal, Hirsch, Yoel, and Meiner, Vardiella
- Abstract
Background Neurodevelopmental disorders (NDDs) impact both the development and functioning of the brain and exhibit clinical and genetic variability. RAP and RAB proteins, belonging to the RAS superfamily, are identified as established contributors to NDDs. However, the involvement of SGSM (small G protein signalling modulator), another member of the RAS family, in NDDs has not been previously documented. Methods Proband-only or trio exome sequencing was performed on DNA samples obtained from affected individuals and available family members. The variant prioritisation process focused on identifying rare deleterious variants. International collaboration aided in the identification of additional affected individuals. Results We identified 13 patients from 8 families of Ashkenazi Jewish origin who all carried the same homozygous frameshift variant in SGSM3 gene. The variant was predicted to cause a loss of function, potentially leading to impaired protein structure or function. The variant co-segregated with the disease in all available family members. The affected individuals displayed mild global developmental delay and mild to moderate intellectual disability. Additional prevalent phenotypes observed included hypotonia, behavioural challenges and short stature. Conclusions An Ashkenazi Jewish homozygous founder variant in SGSM3 was discovered in individuals with NDDs and short stature. This finding establishes a connection between another member of the RAS family and NDDs. Additional research is needed to uncover the specific molecular mechanisms by which SGSM3 influences neurodevelopmental processes and the regulation of growth. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
5. Intellectual disability syndrome associated with a homozygous founder variant in SGSM3in Ashkenazi Jews
- Author
-
Birnbaum, Rivka, Ezer, Shlomit, Lotan, Nava Shaul, Eilat, Avital, Sternlicht, Keren, Benyamini, Lilach, Reish, Orit, Falik-Zaccai, Tzipora, Ben-Gad, Gali, Rod, Raya, Segel, Reeval, Kim, Katherine, Burton, Barabra, Keegan, Catherine E, Wagner, Mallory, Henderson, Lindsay B, Mor, Nofar, Barel, Ortal, Hirsch, Yoel, Meiner, Vardiella, Elpeleg, Orly, Harel, Tamar, and Mor-Shakad, Hagar
- Abstract
BackgroundNeurodevelopmental disorders (NDDs) impact both the development and functioning of the brain and exhibit clinical and genetic variability. RAP and RAB proteins, belonging to the RAS superfamily, are identified as established contributors to NDDs. However, the involvement of SGSM (small G protein signalling modulator), another member of the RAS family, in NDDs has not been previously documented.MethodsProband-only or trio exome sequencing was performed on DNA samples obtained from affected individuals and available family members. The variant prioritisation process focused on identifying rare deleterious variants. International collaboration aided in the identification of additional affected individuals.ResultsWe identified 13 patients from 8 families of Ashkenazi Jewish origin who all carried the same homozygous frameshift variant in SGSM3gene. The variant was predicted to cause a loss of function, potentially leading to impaired protein structure or function. The variant co-segregated with the disease in all available family members. The affected individuals displayed mild global developmental delay and mild to moderate intellectual disability. Additional prevalent phenotypes observed included hypotonia, behavioural challenges and short stature.ConclusionsAn Ashkenazi Jewish homozygous founder variant in SGSM3was discovered in individuals with NDDs and short stature. This finding establishes a connection between another member of the RAS family and NDDs. Additional research is needed to uncover the specific molecular mechanisms by which SGSM3 influences neurodevelopmental processes and the regulation of growth.
- Published
- 2024
- Full Text
- View/download PDF
6. Carrier screening for Krabbe disease in an isolated inbred community
- Author
-
Ezer, Shlomit, primary, Zuckerman, Shachar, additional, Segel, Reeval, additional, and Zlotogora, Joël, additional
- Published
- 2022
- Full Text
- View/download PDF
7. Infantile SOD1 deficiency syndrome caused by a homozygous SOD1 variant with absence of enzyme activity
- Author
-
Ezer, Shlomit, Daana, Muhannad, Park, Julien H., Yanovsky-Dagan, Shira, Nordström, Ulrika, Basal, Adily, Edvardson, Simon, Saada, Ann, Otto, Markus, Meiner, Vardiella, Marklund, Stefan L., Andersen, Peter Munch, Harel, Tamar, Ezer, Shlomit, Daana, Muhannad, Park, Julien H., Yanovsky-Dagan, Shira, Nordström, Ulrika, Basal, Adily, Edvardson, Simon, Saada, Ann, Otto, Markus, Meiner, Vardiella, Marklund, Stefan L., Andersen, Peter Munch, and Harel, Tamar
- Abstract
Pathogenic variants in SOD1, encoding superoxide dismutase 1, are responsible for about 20% of all familial amyotrophic lateral sclerosis cases, through a gain-of-function mechanism. Recently, two reports showed that a specific homozygous SOD1 loss-of-function variant is associated with an infantile progressive motor-neurological syndrome. Exome sequencing followed by molecular studies, including cDNA analysis, SOD1 protein levels and enzymatic activity, and plasma neurofilament light chain levels, were undertaken in an infant with severe global developmental delay, axial hypotonia and limb spasticity. We identified a homozygous 3-bp in-frame deletion in SOD1. cDNA analysis predicted the loss of a single valine residue from a tandem pair (p.Val119/Val120) in the wild-type protein, yet expression levels and splicing were preserved. Analysis of SOD1 activity and protein levels in erythrocyte lysates showed essentially no enzymatic activity and undetectable SOD1 protein in the child, whereas the parents had ∼50% protein expression and activity relative to controls. Neurofilament light chain levels in plasma were elevated, implying ongoing axonal injury and neurodegeneration. Thus, we provide confirmatory evidence of a second biallelic variant in an infant with a severe neurological syndrome and suggest that the in-frame deletion causes instability and subsequent degeneration of SOD1. We highlight the importance of the valine residues at positions V119-120, and suggest possible implications for future therapeutics research.
- Published
- 2022
- Full Text
- View/download PDF
8. Infantile SOD1 deficiency syndrome caused by a homozygous SOD1 variant with absence of enzyme activity
- Author
-
Ezer, Shlomit, primary, Daana, Muhannad, additional, Park, Julien H, additional, Yanovsky-Dagan, Shira, additional, Nordström, Ulrika, additional, Basal, Adily, additional, Edvardson, Simon, additional, Saada, Ann, additional, Otto, Markus, additional, Meiner, Vardiella, additional, Marklund, Stefan L, additional, Andersen, Peter Munch, additional, and Harel, Tamar, additional
- Published
- 2021
- Full Text
- View/download PDF
9. Additional file 2 of Functional interpretation of ATAD3A variants in neuro-mitochondrial phenotypes
- Author
-
Yap, Zheng Yie, Park, Yo Han, Wortmann, Saskia B., Gunning, Adam C., Ezer, Shlomit, Sukyeong Lee, Duraine, Lita, Wilichowski, Ekkehard, Wilson, Kate, Mayr, Johannes A., Wagner, Matias, Li, Hong, Kini, Usha, Black, Emily Davis, Monaghan, Kristin G., Lupski, James R., Ellard, Sian, Westphal, Dominik S., Harel, Tamar, and Yoon, Wan Hee
- Abstract
Additional file 2 : Table S2. Primers used for breakpoint junction analyses: Primers used to define breakpoint junctions in families 1-4. Table S3. Missense variants identified in ATAD3A: Bioinformatic predictions of missense variants identified in this study. Figure S1. Homozygous variant in Family 8: Visualization of exome sequencing reads showing the homozygous variant c.980G>C, p.(Arg327Pro). Figure S2. Segregation analysis in Family 7: Data showing that the c.150C>G variant is de novo, whereas the c.1703_1705del variant is maternally inherited. Figure S3. Compound heterozygous deletion affecting ATAD3A in Family 1: Visualization of exome sequencing read alignments indicating two overlapping deletions inherited in trans. Figure S4. Breakpoint junction sequencing of paternally inherited ATAD3B/ATAD3A deletion in Family 1: Alignment to ATAD3B and ATAD3A shows that the breakpoint occurred within a region of identity between the paralogs. Figure S5. Read depth analysis of exome sequencing data in Family 2: The compound heterozygous deletion can be appreciated. Figure S6. Breakpoint junction sequencing of first ATAD3B/ATAD3A deletion in Family 2: Alignment to ATAD3B and ATAD3A shows that the breakpoint occurred within a region of identity between the paralogs. Figure S7. Breakpoint junction sequencing of second inherited ATAD3B/ATAD3A deletion in Family 2: Alignment to ATAD3B and ATAD3A shows that the breakpoint occurred within a region of identity between the paralogs. Figure S8. Confirmatory array data from Family 3: The heterozygous deletion can be appreciated in the proband and mother’s samples, but not in the father’s sample. Figure S9. Breakpoint junction sequencing of maternally inherited ATAD3B/ATAD3A deletion in Family 3: Alignment to ATAD3B and ATAD3A shows that the breakpoint occurred within a region of identity between the paralogs. Figure S10. Breakpoint junction sequencing of paternally inherited 2-exon deletion in ATAD3A (Family 4): Delineation of the breakpoint junction by Sanger sequencing spanning the deletion, and evolutionary conservation of the skipped exons. Figure S11. Schematic diagram of all CNVs identified in this study: Diagram of the six CNVs studied; five of six were resolved at the breakpoint junction level. Figure S12. dAtad3a is expressed ubiquitously in embryos: Confocal micrographs of an embryo expressing GFP protein under the control of dAtad3a-T2A-Gal4 showed that dAtad3a is expressed ubiquitously. Figure S13. R176W and L83V did not affect mitochondria content and morphology in larvae muscles: Mitochondria content and morphology of dAtad3a mutant muscles expressing dAtad3aR176W, or dAtad3aL83V are comparable to those in wildtype controls. Figure S14. dAtad3a null, F56L, G242V, and R333P cause increased mitochondrial content in embryos: Mitochondrial content in dAtad3a null mutant embryo and those expressing dAtad3aF56L, dAtad3aG242V, or dAtad3aR333P is higher than those in wild type control embryos. Figure S15. dAtad3a null, F56L, G242V, and R333P cause increased mitochondrial numbers and size in embryos: In embryo VNC, dAtad3a null mutant and those expressing dAtad3aF56L, dAtad3aG242V, or dAtad3aR333P exhibited an increase in the mitochondrial size and numbers compared to those in wild type controls. Figure S16. R176W causes small mitochondria in adult muscles: dAtad3a mutant muscles expressing dAtad3aR176W exhibited smaller size of mitochondria compared to those expressing dAtad3aWT, or dAtad3aL83V. Figure S17. R176W and L83V cause various defects in mitochondria in adult muscles: dAtad3a mutant muscles expressing dAtad3aR176W, or dAtad3aL83V exhibited small, and membrane-defective mitochondria compared to those expressing dAtad3aL83V.
- Published
- 2021
- Full Text
- View/download PDF
10. Infantile SOD1 deficiency syndrome caused by a homozygous SOD1 variant with absence of enzyme activity.
- Author
-
Ezer S, Daana M, Park JH, Yanovsky-Dagan S, Nordström U, Basal A, Edvardson S, Saada A, Otto M, Meiner V, Marklund SL, Andersen PM, and Harel T
- Subjects
- DNA, Complementary, Humans, Infant, Mutation genetics, Superoxide Dismutase genetics, Superoxide Dismutase metabolism, Superoxide Dismutase-1 genetics, Syndrome, Valine genetics, Amyotrophic Lateral Sclerosis metabolism
- Abstract
Pathogenic variants in SOD1, encoding superoxide dismutase 1, are responsible for about 20% of all familial amyotrophic lateral sclerosis cases, through a gain-of-function mechanism. Recently, two reports showed that a specific homozygous SOD1 loss-of-function variant is associated with an infantile progressive motor-neurological syndrome. Exome sequencing followed by molecular studies, including cDNA analysis, SOD1 protein levels and enzymatic activity, and plasma neurofilament light chain levels, were undertaken in an infant with severe global developmental delay, axial hypotonia and limb spasticity. We identified a homozygous 3-bp in-frame deletion in SOD1. cDNA analysis predicted the loss of a single valine residue from a tandem pair (p.Val119/Val120) in the wild-type protein, yet expression levels and splicing were preserved. Analysis of SOD1 activity and protein levels in erythrocyte lysates showed essentially no enzymatic activity and undetectable SOD1 protein in the child, whereas the parents had ∼50% protein expression and activity relative to controls. Neurofilament light chain levels in plasma were elevated, implying ongoing axonal injury and neurodegeneration. Thus, we provide confirmatory evidence of a second biallelic variant in an infant with a severe neurological syndrome and suggest that the in-frame deletion causes instability and subsequent degeneration of SOD1. We highlight the importance of the valine residues at positions V119-120, and suggest possible implications for future therapeutics research., (© The Author(s) (2021). Published by Oxford University Press on behalf of the Guarantors of Brain. All rights reserved. For permissions, please email: journals.permissions@oup.com.)
- Published
- 2022
- Full Text
- View/download PDF
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.